FTC Health Product Enforcement Actions Target Products With $1 Bil. In Sales
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission has filed or settled 17 enforcement actions against "parties engaged in false or misleading advertising of dietary supplements and other [health] products" since December
You may also be interested in...
Enzyte Male Enhancement Program Claims Overly Enhanced
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says
Enzyte Male Enhancement Program Claims Overly Enhanced
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says
Enzyte Male Enhancement Program Claims Overly Enhanced
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says